Health
With demand uncertain and its U.S. manufacturing in limbo, AstraZeneca still aims to seek FDA nod for COVID-19 vaccine – FiercePharma
AstraZeneca’s target window to apply for emergency use authorization of its troubled COVID-19 vaccine in the U.S. has passed. But the company still plans to seek…
Its COVID-19 vaccine has been vilified and its manufacturing network has been questioned, but AstraZeneca is still planning to apply for emergency use authorization of its shot in the U.S., a company spokesman confirmed.
A month ago, after AZ said its vaccine succeeded in phase 3 testing, an AstraZeneca executive said the company would apply for an emergency nod in America in the first half of April.
Assuming that the approval will take place in a fast way, we hope to deliver 30 million doses instantly,…
-
General21 hours agoAshes engulfed by fresh DRS controversy as TV umpire gives Jamie Smith out despite RTS ‘murmur’
-
Noosa News5 hours agoTwo teenagers and two adults rushed to hospital in life-threatening conditions after shocking Lawnton house fire
-
Noosa News22 hours agoBrisbane widow’s $6 million prize home win comes with unexpected luxury
-
Noosa News6 hours agoFatal traffic crash, Noosa – Sunshine Coast